These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. S100a8/a9 released by CD11b+Gr1+ neutrophils activates cardiac fibroblasts to initiate angiotensin II-Induced cardiac inflammation and injury. Wu Y; Li Y; Zhang C; A X; Wang Y; Cui W; Li H; Du J Hypertension; 2014 Jun; 63(6):1241-50. PubMed ID: 24711518 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of pro-inflammatory myeloid cell responses by short-term S100A9 blockade improves cardiac function after myocardial infarction. Marinković G; Grauen Larsen H; Yndigegn T; Szabo IA; Mares RG; de Camp L; Weiland M; Tomas L; Goncalves I; Nilsson J; Jovinge S; Schiopu A Eur Heart J; 2019 Aug; 40(32):2713-2723. PubMed ID: 31292614 [TBL] [Abstract][Full Text] [Related]
4. S100A8/A9 in Inflammation. Wang S; Song R; Wang Z; Jing Z; Wang S; Ma J Front Immunol; 2018; 9():1298. PubMed ID: 29942307 [TBL] [Abstract][Full Text] [Related]
5. S100A8 and S100A9 Are Important for Postnatal Development of Gut Microbiota and Immune System in Mice and Infants. Willers M; Ulas T; Völlger L; Vogl T; Heinemann AS; Pirr S; Pagel J; Fehlhaber B; Halle O; Schöning J; Schreek S; Löber U; Essex M; Hombach P; Graspeuntner S; Basic M; Bleich A; Cloppenborg-Schmidt K; Künzel S; Jonigk D; Rupp J; Hansen G; Förster R; Baines JF; Härtel C; Schultze JL; Forslund SK; Roth J; Viemann D Gastroenterology; 2020 Dec; 159(6):2130-2145.e5. PubMed ID: 32805279 [TBL] [Abstract][Full Text] [Related]
6. S100a8/a9 Signaling Causes Mitochondrial Dysfunction and Cardiomyocyte Death in Response to Ischemic/Reperfusion Injury. Li Y; Chen B; Yang X; Zhang C; Jiao Y; Li P; Liu Y; Li Z; Qiao B; Bond Lau W; Ma XL; Du J Circulation; 2019 Aug; 140(9):751-764. PubMed ID: 31220942 [TBL] [Abstract][Full Text] [Related]
7. Role of S100A8/A9 for Cytokine Secretion, Revealed in Neutrophils Derived from ER-Hoxb8 Progenitors. Zhou Y; Hann J; Schenten V; Plançon S; Bueb JL; Tolle F; Bréchard S Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445548 [TBL] [Abstract][Full Text] [Related]
8. S100A8/A9: From basic science to clinical application. Pruenster M; Vogl T; Roth J; Sperandio M Pharmacol Ther; 2016 Nov; 167():120-131. PubMed ID: 27492899 [TBL] [Abstract][Full Text] [Related]
9. S100A8 and S100A9 in Cancer. Chen Y; Ouyang Y; Li Z; Wang X; Ma J Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188891. PubMed ID: 37001615 [TBL] [Abstract][Full Text] [Related]
10. S100A8 & S100A9: Alarmin mediated inflammation in tendinopathy. Crowe LAN; McLean M; Kitson SM; Melchor EG; Patommel K; Cao HM; Reilly JH; Leach WJ; Rooney BP; Spencer SJ; Mullen M; Chambers M; Murrell GAC; McInnes IB; Akbar M; Millar NL Sci Rep; 2019 Feb; 9(1):1463. PubMed ID: 30728384 [TBL] [Abstract][Full Text] [Related]
11. Hypoxia and HIF-1 increase S100A8 and S100A9 expression in prostate cancer. Grebhardt S; Veltkamp C; Ströbel P; Mayer D Int J Cancer; 2012 Dec; 131(12):2785-94. PubMed ID: 22505354 [TBL] [Abstract][Full Text] [Related]
12. Observational study on Swedish plaque psoriasis patients receiving narrowband-UVB treatment show decreased S100A8/A9 protein and gene expression levels in lesional psoriasis skin but no effect on S100A8/A9 protein levels in serum. Duvetorp A; Söderman J; Assarsson M; Skarstedt M; Svensson Å; Seifert O PLoS One; 2019; 14(3):e0213344. PubMed ID: 30865695 [TBL] [Abstract][Full Text] [Related]
13. Comparison of mRNA, Protein, and Urinary Nucleic Acid Levels of S100A8 and S100A9 between Prostate Cancer and BPH. Yun SJ; Yan C; Jeong P; Kang HW; Kim YH; Kim EA; Lee OJ; Kim WT; Moon SK; Kim IY; Choi YH; Kim WJ Ann Surg Oncol; 2015 Jul; 22(7):2439-45. PubMed ID: 25348783 [TBL] [Abstract][Full Text] [Related]
14. NETosis Is Required for S100A8/A9-Induced Granulopoiesis After Myocardial Infarction. Nagareddy PR; Sreejit G; Abo-Aly M; Jaggers RM; Chelvarajan L; Johnson J; Pernes G; Athmanathan B; Abdel-Latif A; Murphy AJ Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2805-2807. PubMed ID: 32878477 [TBL] [Abstract][Full Text] [Related]
15. Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies. Wagner NB; Weide B; Gries M; Reith M; Tarnanidis K; Schuermans V; Kemper C; Kehrel C; Funder A; Lichtenberger R; Sucker A; Herpel E; Holland-Letz T; Schadendorf D; Garbe C; Umansky V; Utikal J; Gebhardt C J Immunother Cancer; 2019 Dec; 7(1):343. PubMed ID: 31806053 [TBL] [Abstract][Full Text] [Related]
16. Secretion of the Phosphorylated Form of S100A9 from Neutrophils Is Essential for the Proinflammatory Functions of Extracellular S100A8/A9. Schenten V; Plançon S; Jung N; Hann J; Bueb JL; Bréchard S; Tschirhart EJ; Tolle F Front Immunol; 2018; 9():447. PubMed ID: 29593718 [TBL] [Abstract][Full Text] [Related]
17. S100A8/A9 promotes parenchymal damage and renal fibrosis in obstructive nephropathy. Tammaro A; Florquin S; Brok M; Claessen N; Butter LM; Teske GJD; de Boer OJ; Vogl T; Leemans JC; Dessing MC Clin Exp Immunol; 2018 Sep; 193(3):361-375. PubMed ID: 29746703 [TBL] [Abstract][Full Text] [Related]
18. S100A8/A9 Is a Marker for the Release of Neutrophil Extracellular Traps and Induces Neutrophil Activation. Sprenkeler EGG; Zandstra J; van Kleef ND; Goetschalckx I; Verstegen B; Aarts CEM; Janssen H; Tool ATJ; van Mierlo G; van Bruggen R; Jongerius I; Kuijpers TW Cells; 2022 Jan; 11(2):. PubMed ID: 35053354 [TBL] [Abstract][Full Text] [Related]
19. S100A8/A9 increases the mobilization of pro-inflammatory Ly6C Cremers NAJ; van den Bosch MHJ; van Dalen S; Di Ceglie I; Ascone G; van de Loo F; Koenders M; van der Kraan P; Sloetjes A; Vogl T; Roth J; Geven EJW; Blom AB; van Lent PLEM Arthritis Res Ther; 2017 Sep; 19(1):217. PubMed ID: 28969686 [TBL] [Abstract][Full Text] [Related]